Ampersand Capital Partners

Lentiviral vector GMP CDMO based in San Sebastian, Spain; leadership appointment reported in 2025.

#Pharma Services / CDMO (lentiviral vector manufacturing)

Global provider of active healing and surgical orthobiologics; completed an IPO in June 2024.

#Specialty Products (orthobiologics)

Provider of clinical and commercial viral vector supply for in vivo gene and ex vivo cell therapies; notable exit via sale to Thermo Fisher.

#Pharma Services / CDMO (viral vectors)

Provider of peptide synthesis and bioanalytical technology for research and development; acquired by Mesa Laboratories in 2019.

#Laboratory Products (peptide synthesis, bioanalytical technology)

Manufacturer of agglomerated and microencapsulated food and nutrition ingredients; acquired by Balchem Corporation in 2017.

#Specialty Products / Nutrition ingredients (manufacturer)

Provider of complex molecular analysis for early cancer diagnosis and treatment support.

#Laboratory Services (molecular analysis for cancer diagnosis)

Founded 2015 and headquartered in Rochester, NY; provides preclinical, clinical, and consulting services with a focus in ophthalmology and medical device clinical research. Announced acquisition of Promedica International (January 18, 2024).

#Laboratory Services / CRO (preclinical and clinical development, consulting)

Collection and fractionation of blood plasma for production of plasma-derived therapies.

#Specialty Products (plasma-derived therapies)

Provider of antibody engineering, discovery, protein chemistry, bioexpression and bioanalytics; acquired by Curia in 2021.

#Pharma Services (antibody engineering, discovery, and bioanalytics)

Manufacturer of in vivo antibodies for flow cytometry, immunohistochemistry, and spatial biology studies.

#Laboratory Products (in vivo antibodies)

Designs and manufactures endoscopic stapling devices for surgical procedures.

#Medical Devices (endoscopic stapling devices)

Developed solutions for identification and protection of those at risk of lead exposure; acquired by Meridian Biosciences in 2016.

#Laboratory Products / Diagnostics

Developer of compact, portable, and benchtop nuclear magnetic resonance and MRI products.

#Laboratory Products (NMR and MRI instruments)

Preclinical CRO providing bioanalytical, pharmacokinetic, and pharmacology studies.

#Laboratory Services (preclinical CRO)

Provides topical and transdermal product design, development, and manufacturing services.

#Pharma Services / CDMO (topical and transdermal development and manufacturing)

Designer and manufacturer of medical technology solutions for minimally invasive surgical devices; acquired by Helix Medical / Freudenberg affiliates.

#Medical Devices (minimally invasive surgical devices)

Specialty CRO providing cryo-EM solutions for discovery and development of therapeutics.

#Laboratory Services (cryo-EM solutions)

Developer of automated cell counting and image cytometry systems; acquired by PerkinElmer in 2021.

#Laboratory Products (automated cell counting and image cytometry)

Provides R&D solutions for immunotherapeutics, antiviral drugs, and cell and gene therapies; acquired by Q2 Solutions in 2022.

#Pharma Services / R&D solutions (immunotherapeutics development)

Supplier of instruments and assays for life sciences research.

#Laboratory Products (instruments and assays)

Provider of clinical and epidemiology research solutions with a focus on vaccines and infectious diseases.

#Pharma Services (clinical and epidemiology research)

CDMO offering nanoparticle-based drug delivery solutions.

#Pharma Services / CDMO (nanoparticle-based drug delivery)

Provides medical device coating application services and value-added surface treatments; acquired by Integer in 2025.

#Medical Device Services (coating and surface treatments)

Provides drug product services from pre-formulation and clinical development through scale-up and commercial manufacturing.

#Pharma Services / CDMO (drug product services)

Analytical testing for raw materials, formulated products, packaging, and medical devices.

#Laboratory Services (analytical testing)

Compounding pharmacy focused on the companion animal market; acquired by Vets First Choice in 2017.

#Specialty Products / Compounding Pharmacy (veterinary)

Pioneering laboratory for microarray-based cytogenetic diagnostics; acquired by PerkinElmer in 2010.

#Laboratory Services (cytogenetic diagnostics)

Designs and manufactures FTIR accessories, sample preparation/XRF, process cells and related spectroscopy products.

#Laboratory Products (FTIR accessories and sample preparation)

Provides high-throughput solutions for automated workflows in pharmaceutical and CDMO applications.

#Laboratory Products / Instruments (high-throughput analytical systems)

Provides contract packaging and supply chain management services.

#Contract Packaging and Supply Chain

Medical device developer offering design and manufacturing services.

#Medical Devices (design and manufacturing)

mRNA CDMO focused on mRNA, LNP-mRNA, and associated services.

#Pharma Services / CDMO (mRNA and LNP-mRNA)

Developer and manufacturer of suspension and adherent cell-based and egg-based virus manufacturing; acquired by Recipharm in 2022.

#Pharma Services / Viral manufacturing

Diagnostic laboratory specializing in infectious diseases, immunology, and allergy testing; acquired by Eurofins Scientific in 2014.

#Laboratory Services (infectious disease diagnostics)

Custom peptide synthesis and antibody production; acquired by Biosynth Carbosynth in 2022.

#Laboratory Services (peptide synthesis and antibody production)